Stephen P. McDonald

Stephen P. McDonald

Auto-generated profile, based on publicly available information

Stephen P. McDonald

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry South Australian Health and Medical Research Institute (SAHMRI) Adelaide South Australia Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2004 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
SMStephen P. McDonald
Stephen P. McDonald
JCJonathan C. Craig
Jonathan C. Craig
Although renal-replacement therapy for children with end-stage renal disease has been used for several decades, data on patients' long-term survival are sparse.

1 January 2009 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SMStephen P. McDonald
Stephen P. McDonald
MMMark R. Marshall
Mark R. Marshall
DJDavid Johnson
David Johnson
KPKevan R. Polkinghorne
Kevan R. Polkinghorne
Mortality differences between peritoneal dialysis (PD) and hemodialysis (HD) are widely debated. In this study, mortality was compared between patients treated with PD and HD (including home HD) using data from 27,015 patients in the Australia and New Zealand Dialysis and Transplant Registry, 25,287 of whom were still receiving PD or HD 90 d after entry into the registry. Overall mortality rates were significantly lower during the 90- to 365-d period among those being treated with PD at day 90 (adjusted hazard ratio [HR] 0.89; 95% confidence interval [CI] 0.81 to 0.99]; P < 0.001). This effect, however, varied in direction and size with the presence of comorbidities: Younger patients without comorbidities had a mortality advantage with PD treatment, but other groups did not. After 12 mo, the use of PD at day 90 was associated with significantly increased mortality (adjusted HR 1.33; 95% CI 1.24 to 1.42; P < 0.001). In a supplementary as-treated analysis, PD treatment was associated with lower mortality during the first 90 d (adjusted HR 0.67; 95% CI 0.56 to 0.81; P < 0.001). These data suggest that the effect of dialysis modality on survival for an individual depends on time, age, and presence of comorbidities. Treatment with PD may be advantageous initially but may be associated with higher mortality after 12 mo.

1 November 2003 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SMStephen P. McDonald
Stephen P. McDonald
JCJohn F. Collins
John F. Collins
DJDavid Johnson
David Johnson
: Although obesity is associated with increased risks of morbidity and death in the general population, a number of studies of patients undergoing hemodialysis have demonstrated that increasing body mass index (BMI) is correlated with decreased mortality risk. Whether this association holds true among patients treated with peritoneal dialysis (PD) has been less well studied. The aim of this investigation was to examine the association between BMI and outcomes among new PD patients in a large cohort, with long-term follow-up monitoring. Using data from the Australia and New Zealand Dialysis and Transplant Registry, an analysis of all new adult patients (n = 9679) who underwent an episode of PD treatment in Australia or New Zealand between April 1, 1991, and March 31, 2002, was performed. Patients were classified as obese (BMI of ≥30 kg/m2), overweight (BMI of 25.0 to 29.9 kg/m2), normal weight (BMI of 20 to 24.9 kg/m2), or underweight (BMI of <20 kg/m2). In multivariate analyses, obesity was independently associated with death during PD treatment (hazard ratio, 1.36; 95% confidence interval, 1.14 to 1.54; P < 0.05) and technique failure (hazard ratio, 1.17; 95% confidence interval, 1.07 to 1.26; P < 0.01), except among patients of New Zealand Maori/Pacific Islander origin, for whom there was no significant relationship between BMI and death during PD treatment. A supplementary fractional polynomial analysis modeled BMI as a continuous predictor and indicated a J-shaped relationship between BMI and patient mortality rates and a steady increase in death-censored technique failure rates up to a BMI of 40 kg/m2; the mortality risk was lowest for BMI values of approximately 20 kg/m2. In conclusion, obesity at the commencement of renal replacement therapy is a significant risk factor for death and technique failure. Such patients should be closely monitored during PD and should be considered for early transfer to an alternative renal replacement therapy if difficulties are experienced. E-mail: stephenm@ anzdata.org.au

27 October 2017 in Environmental Health
Verified
Journal Article
Open access
PDF file
MBMatthew Borg
Matthew Borg
PBPeng Bi
Peng Bi
MNMonika Nitschke
Monika Nitschke
SWSusan Williams
Susan Williams
SMStephen McDonald
Stephen McDonald
Extremely high temperatures over many consecutive days have been linked to an increase in renal disease in several cities. This is becoming increasingly relevant with heatwaves becoming longer, more intense, and more frequent with climate change. This study aimed to extend the known relationship between daily temperature and kidney disease to include the incidence of eight temperature-prone specific renal disease categories – total renal disease, urolithiasis, renal failure, acute kidney injury (AKI), chronic kidney disease (CKD), urinary tract infections (UTIs), lower urinary tract infections (LUTIs) and pyelonephritis. Daily data was acquired for maximum, minimum and average temperature over the period of 1 July 2003 to 31 March 2014 during the warm season (October to March) in Adelaide, South Australia. Data for daily admissions to all metropolitan hospitals for renal disease, including 83,519 emergency department admissions and 42,957 inpatient admissions, was also obtained. Renal outcomes were analyzed using time-stratified negative binomial regression models, with the results aggregated by day. Incidence rate ratios (IRR) and 95% confidence intervals (CI) were estimated for associations between the number of admissions and daily temperature. Increases in daily temperature per 1 °C were associated with an increased incidence for all renal disease categories except for pyelonephritis. Minimum temperature was associated with the greatest increase in renal disease followed by average temperature and then maximum temperature. A 1°C increase in daily minimum temperature was associated with an increase in daily emergency department admissions for AKI (IRR 1.037, 95% CI: 1.026–1.048), renal failure (IRR 1.030, 95% CI: 1.022–1.039), CKD (IRR 1.017, 95% CI: 1.001–1.033) urolithiasis (IRR 1.015, 95% CI: 1.010–1.020), total renal disease (IRR 1.009, 95% CI: 1.006–1.011), UTIs (IRR 1.004, 95% CI: 1.000–1.007) and LUTIs (IRR 1.003, 95% CI: 1.000–1.006). An increased frequency of renal disease, including urolithiasis, acute kidney injury and urinary tract infections, is predicted with increasing temperatures from climate change. These results have clinical and public health implications for the management of renal diseases and demand tailored health services. Future research is warranted to analyze individual renal diseases with more comprehensive information regarding renal risk factors, and studies examining mortality for specific renal diseases.

1 December 2002 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
SMStephen P. McDonald
Stephen P. McDonald
GRGraeme R. Russ
Graeme R. Russ
Background. Comparison of mortality rates after kidney transplantation with those treated by dialysis is an important factor is assessing treatment options, but is subject to many pitfalls in selection of appropriate control groups, in particular allowing for varying post‐operative risk, and recent changes in mortality rates with better immunosuppression and dialysis techniques. We examined the outcomes following cadaveric renal transplantation and compared them with an appropriate control group of dialysis patients, using contemporary national data from Australia and New Zealand and appropriate statistical methods. In particular, we explicitly addressed the changing risks following transplantation, and looked at both younger (low‐risk) and older (higher‐risk) recipients, and examined the effect of attribution of deaths in the early period following loss of transplant function to the risk of transplantation. Methods. We performed a cohort study, initially including 11 560 people aged 15–65 years who began treatment for end‐stage renal disease in Australia or New Zealand between 1991 and 2000. Of these, 5144 were recorded at least once as on an active cadaveric transplant waiting list. Survival was analysed with Cox regression, including time‐dependent covariates to allow for the violation of proportional hazards with changing mortality risks post‐operatively. We also performed stratified analyses on low‐risk recipients (<50 years, without co‐morbidity) and older recipients. Results. There was a clear difference in survival between those on the active transplant waiting list and those not listed. Of those who were on the cadaveric transplant waiting list, 2362 (46%) were transplanted in the period to 30 September 2001. Cadaveric transplantation was associated with an initial increase in mortality [during the first 3 months post‐transplantation, adjusted HR 2.0 (1.5–2.7), P<0.001]. This fell below the dialysis group at 6 months [adjusted HR 0.27 (0.16–0.47), P<0.001] and from 12 months post‐transplantation, the reduction in risk of mortality was ∼80% [adjusted HR 0.19 (0.15–0.24), P<0.001]. A secondary analysis showed the excess risk attributed to the period immediately following transplantation was actually due to deaths in the 60 days after loss of transplant function rather than those occurring with a functioning graft. Conclusions. As well as improved quality of life, cadaveric renal transplantation in Australia and New Zealand is associated with a survival advantage compared with those remaining on the waiting list.

1 July 2004 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Open access
PDF file
SMStephen P. McDonald
Stephen P. McDonald
JCJohn F. Collins
John F. Collins
MRMarkus Rumpsfeld
Markus Rumpsfeld
DJDavid W. Johnson
David W. Johnson
Objective: The aim of the present investigation was to examine the association between body mass index (BMI) and peritonitis rates among incident peritoneal dialysis (PD) patients in a large cohort with long-term follow-up. Design: Retrospective observational cohort study of the Australian and New Zealand PD patient population. Setting: Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry. Participants: The study included all incident adult patients ( n = 10 709) who received PD in Australia and New Zealand in the 12-year period between 1 April 1991 and 31 March 2003. Patients were classified as obese (BMI ≥ 30 kg/m2), overweight (BMI 25.0 – 29.9 kg/m2), normal weight (20 – 24.9 kg/m2), or underweight (< 20 kg/m2). Main Measurements: Time to first peritonitis and episodes of peritonitis per patient-year were recorded over the 12-year period. Results: Higher BMI was associated with a shorter time to first peritonitis episode, independent of other risk factors [hazard ratio 1.08 for each 5-kg/m2 increase in BMI, 95% confidence interval (CI) 1.04 – 1.12, p < 0.001]. When peritonitis outcomes were analyzed as episodes of peritonitis per patient-year, these rates were significantly higher among patients with higher BMI: underweight 0.69 episodes/year (95% CI 0.66 – 0.73), normal weight 0.79 (95% CI 0.77 – 0.81), overweight 0.88 (95% CI 0.85 – 0.90), obese 1.06 (95% CI 1.02 – 1.09). Coronary artery disease and chronic lung disease were associated with both shorter time to first peritonitis and higher peritonitis rates, independently of these other factors. There was also a “vintage effect,” with lower peritonitis rates seen among people who commenced dialysis in more recent years. Conclusions: Higher BMI at the commencement of renal replacement therapy is a significant risk factor for peritonitis. The mechanisms for this remain undefined.